Background: Hepatocellular carcinoma (HCC) accounts for approximately 80% of all the primary malignant tumors of the liver. Hepatoblastoma (HBL) is the most common primary malignant neoplasm of the liver in childhood, and extremely rare in adults. To the best of our knowledge, this is the first report of an adult case with cytopathologic description of a combined HCC and HBL, occurring in a noncirrhotic liver. Case: A 24-year-old male was admitted to the hospital with right-sided abdominal pain. Masses in the liver were detected radiologically. Fine-needle aspiration biopsy and core-needle biopsy revealed a malignant hepatocellular tumor with features of both HCC and HBL. Conclusion: In the present case among the distinct HCC cell groups, areas of smaller and more primitive cells consistent with embryonal type HBL and some other groups of cells with intermediate morphology were observed. These findings suggested the probable single stem cell origin of the tumor with differentiation to both cell groups rather than a combination of two different tumors. Therefore, the term ‘malignant hepatocellular tumor’ could also be considered to define this particular tumor. This case provides support to the previous reports in which HBL areas are described in HCC.

Keywords:
Hepatoblastoma, Hepatocellular carcinoma, Cytopathology, Fine-needle aspiration
1.
Tannapfel A, Wittekind C: Genes involved in hepatocellular carcinoma: deregulation in cell cycling and apoptosis. Virchows Arch 2002;440:345–352.
2.
Tischoff I, Markwarth A, Witzigmann H, Uhlmann D, Hauss J, et al: Allele loss and epigenetic inactivation of 3p21.3 in malignant liver tumors. Int J Cancer 2005;115:684–689.
3.
Leonard A, Alyond D, Fischel R: Hepatoblastoma and hepatocellular carcinoma. Surg Clin North Am 1985;65:1903–1906.
4.
De-Potter CR, Robberecht E, Laureys G, Cuvelier CA: Hepatitis B related childhood hepatocellular carcinoma: childhood hepatic malignancies. Cancer 1987:60:414–418.
5.
Ohaki Y, Misugi K, Sasaki Y, et al: Hepatitis B surface antigen positive hepatocellular carcinoma in children: report of a case and review of the literature. Cancer 1983;51:822–828.
6.
Gauthier F, Valayer J, Thai BL, Sinico M, Kalifa C: Hepatoblastoma and hepatocarcinoma in children: analysis of a series of 29 cases. J Pediatr Surg 1986;21:424–429.
7.
Postovsky S, Elhasid R, Otte GB, Ben Itzhak O, Gaitini D, Weyl Ben Arush M: Late recurrence of combined hepatocellular carcinoma and hepatoblastoma in a child: case report and review of the literature. Eur J Pediatr Surg 2001;11:61–65.
8.
Suriawinata AA, Thung SN: Malignant liver tumors. Clin Liver Dis 2002;6:527–554.
9.
Lau WY, Lai EC: Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis Int 2008;7:237–257.
10.
Chaparro M, Gonzalez Moreno L, Trapero-Marugan M, Medina JR, Moreno-Otero R: Review article: pharmacological therapy for hepatocellular carcinoma with sorafenib and other oral agents. Aliment Pharmacol Ther 2008;28:1269–1277.
11.
Greten TF, Papendorf F, Bleck JS, Kirchhoff T, Wohlberedt T, Kubicka S, Klempnauer J, Galanski M, Manns MP: Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients. Br J Cancer 2005;92:1862–1868.
12.
Raney B: Hepatoblastoma in children: a review. J Pediatr Hematol Oncol 1997;19:418–422.
13.
MacSween RNM, Anthony PP, Scheuer PF, Burt AD, Portmann BC: Pathology of the liver. New York, Churchill Livingstone, 1994, p 666.
14.
Remes-Troche JM, Montaño-Loza A, Meza-Junco J, García-Leiva J, Torre-Delgadillo A: Hepatoblastoma in adult age: a case report and literature review. Ann Hepatol 2006;5:179–181.
15.
Lugli A, Tornillo L, Mirlacher M, Bundi M, Sauter G, Terracciano LM: Hepatocyte paraffin 1 expression in human normal and neoplastic tissues: tissue microarray analysis on 3,940 tissue samples. Am J Clin Pathol 2004;122:721–727.
16.
Badve S, Logdberg L, Lal A, et al: Small cells in hepatoblastoma lack ‘oval’ cell phenotype. Mod Pathol 2003;16:930–936.
17.
Ruck P, Xiao JC: Stem-like cells in hepatoblastoma. Med Pediatr Oncol 2002;39:504–507.
18.
Fiegel HC, Gluer S, Roth B, Rischewski J, von Schweinitz D, Ure B, Lambrecht W, Kluth D: Stem-like cells in human hepatoblastoma. J Histochem Cytochem 2004;52:1495.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.